Downregulation of the m6A reader YTHDC2 upregulates exosome content in lung adenocarcinoma via inhibiting IFIT and OAS family members

被引:0
|
作者
Yin, Zhixin [1 ,2 ]
Ma, Lifang [1 ,2 ]
Tian, Xiaoting [2 ]
Sun, Qi [2 ]
Zhang, Congcong [1 ]
Wang, Yikun [1 ,2 ]
Miao, Yayou [2 ]
Xue, Xiangfei [1 ,2 ]
Wang, Yongjie [1 ,2 ]
Wang, Jiayi [1 ,2 ]
Zhang, Xiao [2 ]
Hou, Xumin [3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, Dept Clin Lab Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Inst Thorac Oncol, Sch Med, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Dept Cardiol, Shanghai, Peoples R China
关键词
CANCER-CELLS; BINDING; RECOGNITION; TRANSLATION; PROGRESSION; ACTIVATION; RESISTANCE; THERAPIES; PROMOTES; PROTEIN;
D O I
10.1016/j.jbc.2024.107783
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N6-Methyladenosine 6-Methyladenosine (m6A) 6 A) is the most prevalent mRNA modification. fi cation. Its biological function primarily relies on its "Reader" protein, such as YTHDC2. Previous studies have shown that YTHDC2 downregulation is a procarcinogenic phenomenon in lung adenocarcinoma (LUAD). However, further investigation is needed to understand the molecular mechanisms of downstream genes and the associated biological phenomena following YTHDC2 downregulation. Here, we found that YTHDC2 knockout upregulated exosome content in LUAD. Following YTHDC2 knockout, the mRNA levels of OAS family members (OASs) and IFIT family members (IFITs) also decreased; and inhibition of OASs and IFITs could promote exosome content. Several m6A 6 A modification fi cation sites on the NT domain of OASs and the TPR12 domain of IFITs were found to increase the stability of OASs and IFITs in a YTHDC2dependent manner. OASs and IFITs affected exosome content through target genes including RAB5A, RAB7, and RAB11A, and three arginine (R) amino acids on IFITs were critical for combination IFITs with targeted RAB mRNAs and subsequent degradation. Simultaneously, OASs degraded targeted RABs through RNAseL. Additionally, mutual bindings between OASs and IFITs were critical for their target gene degradation. Collectively, the above fi ndings might provide a theoretical basis for the treatment of LUAD patients with low YTHDC2 expression.
引用
收藏
页数:18
相关论文
共 35 条
  • [1] The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12
    Sun, Yingchuan
    Liu, Yanyan
    Wang, Pengyuan
    Chang, Lin
    Huang, Jianmin
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (05) : 1051 - 1061
  • [2] The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12
    Yingchuan Sun
    Yanyan Liu
    Pengyuan Wang
    Lin Chang
    Jianmin Huang
    Molecular Biotechnology, 2024, 66 : 1051 - 1061
  • [3] Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway
    Wang, Jin
    Tan, Lirong
    Jia, Beibei
    Yu, Xiaofan
    Yao, Ruixin
    OUYang, Nan
    Yu, Xueting
    Cao, Xiyuan
    Tong, Jian
    Chen, Tao
    Chen, Rui
    Li, Jianxiang
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (10): : 2633 - 2651
  • [4] The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function
    Ma, Lifang
    Chen, Tianxiang
    Zhang, Xiao
    Miao, Yayou
    Tian, Xiaoting
    Yu, Keke
    Xu, Xin
    Niu, Yongjie
    Guo, Susu
    Zhang, Congcong
    Qiu, Shiyu
    Qiao, Yongxia
    Fang, Wentao
    Du, Lutao
    Yu, Yongchun
    Wang, Jiayi
    REDOX BIOLOGY, 2021, 38
  • [5] Effects of m6A RNA methylated reader protein YTHDC2 in cigarette smoke induced lung cancer
    Li, Jianxiang
    Wang, Jin
    CANCER SCIENCE, 2024, 115 : 544 - 544
  • [6] The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer
    Liu, Tianyu
    Tang, Wentao
    Chen, Yijiao
    Liu, Yu
    Xu, Donghao
    Jiang, Yudong
    Zhou, Shizhao
    Qin, Xiaorui
    Ren, Li
    Chang, Wenju
    Xu, Jianmin
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [7] Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency
    McGlacken-Byrne, Sinead M.
    del Valle, Ignacio
    Stabej, Polona Le Quesne
    Bellutti, Laura
    Garcia-Alonso, Luz
    Ocaka, Louise A.
    Ishida, Miho
    Suntharalingham, Jenifer P.
    Gagunashvili, Andrey
    Ogunbiyi, Olumide K.
    Mistry, Talisa
    Buonocore, Federica
    Crespo, Berta
    Moreno, Nadjeda
    Niola, Paola
    Brooks, Tony
    Brain, Caroline E.
    Dattani, Mehul T.
    Kelberman, Daniel
    Vento-Tormo, Roser
    Lagos, Carlos F.
    Livera, Gabriel
    Conway, Gerard S.
    Achermann, John C.
    JCI INSIGHT, 2022, 7 (05)
  • [8] Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency
    McGlacken-Byrne, Sinead M.
    Torres, Ignacio Del Valle
    Stabej, Polona Le Quesne
    Belutti, Laura
    Ocaka, Louise
    Ishida, Miho
    Suntharalingham, Jenifer P.
    Dattani, Mehul T.
    Kelberman, Dan
    Lagos, Carlos F.
    Livera, Gabriel
    Conway, Gerard S.
    Achermann, John C.
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 93 - 93
  • [9] The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer
    Liu, Tianyu
    Tang, Wentao
    Chen, Yijiao
    Liu, Yu
    Xu, Donghao
    Jiang, Yudong
    Zhou, Shizhao
    Qin, Xiaorui
    Ren, Li
    Chang, Wenju
    Xu, Jianmin
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [10] Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma
    Ma, Lifang
    Zhang, Xiao
    Yu, Keke
    Xu, Xin
    Chen, Tianxiang
    Shi, Yi
    Wang, Yikun
    Qiu, Shiyu
    Guo, Susu
    Cui, Jiangtao
    Miao, Yayou
    Tian, Xiaoting
    Du, Lutao
    Yu, Yongchun
    Xia, Jinjing
    Wang, Jiayi
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 168 : 25 - 43